LifeMD (LFMD) News Today → Biden FINISHED On June 13th? (From Paradigm Press) (Ad) Free LFMD Stock Alerts $9.41 -0.12 (-1.26%) (As of 01:45 PM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 14 at 4:26 AM | americanbankingnews.comLifeMD's (LFMD) Buy Rating Reaffirmed at HC WainwrightMay 13 at 5:45 AM | americanbankingnews.comLifeMD (NASDAQ:LFMD) Price Target Raised to $15.00 at Cantor FitzgeraldMay 13 at 1:22 AM | americanbankingnews.comPono Capital Two (NASDAQ:PTWO) versus LifeMD (NASDAQ:LFMD) Head-To-Head ContrastMay 10, 2024 | markets.businessinsider.comBuy Rating Affirmed for LifeMD on Strong Q1 Revenue Growth and Upbeat 2024 OutlookMay 10, 2024 | finance.yahoo.comLifeMD First Quarter 2024 Earnings: Revenues Beat Expectations, EPS LagsMay 10, 2024 | marketbeat.comLifeMD (NASDAQ:LFMD) Given Buy Rating at HC WainwrightHC Wainwright reissued a "buy" rating and issued a $12.00 price objective on shares of LifeMD in a research report on Friday.May 10, 2024 | americanbankingnews.comCritical Survey: LifeMD (NASDAQ:LFMD) and Pono Capital Two (NASDAQ:PTWO)May 9, 2024 | marketbeat.comCantor Fitzgerald Increases LifeMD (NASDAQ:LFMD) Price Target to $15.00Cantor Fitzgerald boosted their price objective on shares of LifeMD from $13.00 to $15.00 and gave the company an "overweight" rating in a research report on Thursday.May 8, 2024 | markets.businessinsider.comLifeMD Reports First Quarter 2024 Results; Raises Full Year Revenue GuidanceMay 8, 2024 | seekingalpha.comLifeMD, Inc. 2024 Q1 - Results - Earnings Call PresentationMay 8, 2024 | prnewswire.comSHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of LifeMD, Inc. (NASDAQ: LFMD)May 5, 2024 | finance.yahoo.comInstitutions own 31% of LifeMD, Inc. (NASDAQ:LFMD) shares but individual investors control 47% of the companyMay 5, 2024 | americanbankingnews.comFinancial Comparison: Pono Capital Two (NASDAQ:PTWO) and LifeMD (NASDAQ:LFMD)May 2, 2024 | marketbeat.comLifeMD (NASDAQ:LFMD) Sets New 52-Week High at $12.50LifeMD (NASDAQ:LFMD) Sets New 52-Week High at $12.50May 2, 2024 | globenewswire.comLifeMD Becomes the First Virtual Primary Care Provider to Elevate GLP-1 Patient Care with Real-time, At-Home Monitoring of Blood Pressure and Body CompositionMay 1, 2024 | marketbeat.comLifeMD (LFMD) Set to Announce Quarterly Earnings on WednesdayLifeMD (NASDAQ:LFMD) will be releasing earnings after the market closes on Wednesday, May 8, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=588500)April 29, 2024 | globenewswire.comLifeMD Appoints Dr. Calum MacRae to its Board of DirectorsApril 24, 2024 | globenewswire.comLifeMD to Report First Quarter 2024 Financial Results on May 8April 23, 2024 | finance.yahoo.comLifeMD to Participate in Upcoming Investor and Industry Conferences During MayApril 23, 2024 | marketbeat.comLifeMD (NASDAQ:LFMD) Given New $14.00 Price Target at BTIG ResearchBTIG Research increased their price target on LifeMD from $13.00 to $14.00 and gave the company a "buy" rating in a report on Tuesday.April 13, 2024 | marketbeat.comLifeMD, Inc. (NASDAQ:LFMD) Sees Significant Growth in Short InterestLifeMD, Inc. (NASDAQ:LFMD - Get Free Report) was the recipient of a significant increase in short interest during the month of March. As of March 31st, there was short interest totalling 2,650,000 shares, an increase of 37.3% from the March 15th total of 1,930,000 shares. Based on an average daily volume of 762,800 shares, the short-interest ratio is currently 3.5 days. Approximately 8.6% of the company's stock are sold short.April 12, 2024 | markets.businessinsider.comBuy Rating Affirmed for LifeMD Amid Favorable Legal Outlook and Competitive StrengthsApril 9, 2024 | markets.businessinsider.comAlkermes' Sleeping Disorder Studies' Data Look Excellent, Analyst SaysMarch 29, 2024 | marketbeat.comLifeMD, Inc. (NASDAQ:LFMD) Short Interest UpdateLifeMD, Inc. (NASDAQ:LFMD - Get Free Report) was the recipient of a significant decrease in short interest in the month of March. As of March 15th, there was short interest totalling 1,930,000 shares, a decrease of 29.3% from the February 29th total of 2,730,000 shares. Approximately 6.2% of the shares of the stock are sold short. Based on an average daily volume of 907,200 shares, the short-interest ratio is presently 2.1 days.March 25, 2024 | globenewswire.comLifeMD to Participate in the 23rd Annual Needham Virtual Healthcare ConferenceMarch 19, 2024 | marketbeat.comLifeMD Shares Come Back to Life on GLP-1 Business GrowthLifeMD Inc. NASDAQ: LFMD provides telehealth services to consumers in the United States. The medical sector company operates many telehealth brands, including men's telehealth brands RexMD and ShapiroMD, NavaMD female dermatology telehealth, Cleared Allergy Clinic, and LifeMD Primary Care.March 19, 2024 | marketbeat.comLifeMD Shares Come Back to Life on GLP-1 Business Growth LifeMD stock is surging as the company is riding the GLP-1 trend to double-digit revenue growth and projections for 67% earnings growth in 2024March 18, 2024 | marketbeat.comBTIG Research Boosts LifeMD (NASDAQ:LFMD) Price Target to $13.00BTIG Research lifted their price target on LifeMD from $11.00 to $13.00 and gave the stock a "buy" rating in a research report on Friday.March 18, 2024 | marketbeat.comLifeMD, Inc. (NASDAQ:LFMD) Sees Large Increase in Short InterestLifeMD, Inc. (NASDAQ:LFMD - Get Free Report) was the target of a large growth in short interest during the month of February. As of February 29th, there was short interest totalling 2,730,000 shares, a growth of 13.8% from the February 14th total of 2,400,000 shares. Based on an average trading volume of 829,200 shares, the short-interest ratio is currently 3.3 days. Currently, 9.0% of the shares of the company are sold short.March 13, 2024 | finance.yahoo.comLifeMD Full Year 2023 Earnings: Beats ExpectationsMarch 13, 2024 | marketbeat.comCan WeightWatchers Regain its Mojo after Oprah Steps Down? (LFMD)WW International Inc. (NASDAQ: WW) (WeightWatchers) has had a disastrous 2024, with its shares collapsing 66.7% year-to-date (YTD).March 13, 2024 | marketbeat.comCan WeightWatchers Regain Its Mojo after Oprah Steps Down?WW International Inc. NASDAQ: WW (WeightWatchers) has had a disastrous 2024, with its shares collapsing 66.7% year-to-date (YTD). The company made a praiseworthy strategic pivot in 2023, acquiring Sequence Inc. to enter into the GLP-1 clinical weight loss space, gaining the ability to prescribe medications like Novo Nordisk A/V NYSE: NVO owned Ozempic and Wegovy and Eli Lilly& Co. NYSE: LLY GLP-1 agonists like Mounjaro and Zepbound.March 12, 2024 | markets.businessinsider.comLifeMD Poised for Growth: Strong Q4 Performance and Positive FY24 Outlook Reinforce Buy RatingMarch 11, 2024 | marketwatch.comLifeMD Shares Jump on Strong 4QMarch 11, 2024 | globenewswire.comLifeMD Reports Fourth Quarter 2023 ResultsMarch 10, 2024 | markets.businessinsider.comHere's what to expect from LifeMD's earningsMarch 5, 2024 | realmoney.thestreet.comGet Your Shopping List Ready: Here's How to Buy PullbacksMarch 5, 2024 | marketbeat.comHims & Hers Stock Rises On Stimulating Earnings Growth (LFMD)Telehealth platform Hims & Hers has turned the corner into GAAP profitability and is expanding its product portfolio to increase its addressable audienceFebruary 27, 2024 | finance.yahoo.comLifeMD Insiders Placed Bullish Bets Worth US$1.24mFebruary 26, 2024 | finance.yahoo.comLifeMD to Report Fourth Quarter 2023 Financial Results on March 11February 17, 2024 | markets.businessinsider.comAnalysts Are Bullish on These Healthcare Stocks: LifeMD (LFMD), Tandem Diabetes Care (TNDM)February 15, 2024 | finance.yahoo.comLifeMD to Participate in Upcoming Investor Conferences and WebinarFebruary 14, 2024 | realmoney.thestreet.comIt's a Stock Pickers' Market and 4 of My Own Were Up More Than 10% WednesdayFebruary 6, 2024 | realmoney.thestreet.comI'm Adding This Small-Cap Stock to My Watchlist Amid Rotational ActionFebruary 5, 2024 | msn.comMedical Cannabis Pioneer cbdMD Secures $1.2M To Fund Rollout Of Functional Mushroom ProductsJanuary 31, 2024 | finance.yahoo.comLifeMD to Participate in the 11th Annual BTIG MedTech, Digital Health, Life Science & Diagnostic Tools ConferenceJanuary 31, 2024 | finance.yahoo.comLifeMD (NASDAQ:LFMD) shareholders have earned a 49% CAGR over the last five yearsJanuary 23, 2024 | realmoney.thestreet.comFour Small-Caps and One Very Large-Cap I'm Trading as Earnings Season Heats UpJanuary 18, 2024 | finance.yahoo.comLifeMD to Participate in the Maxim Group 2024 Healthcare IT Virtual ConferenceJanuary 13, 2024 | marketbeat.comLifeMD, Inc. (NASDAQ:LFMD) Sees Significant Decline in Short InterestLifeMD, Inc. (NASDAQ:LFMD - Get Free Report) saw a significant drop in short interest during the month of December. As of December 31st, there was short interest totalling 1,400,000 shares, a drop of 29.6% from the December 15th total of 1,990,000 shares. Based on an average trading volume of 863,000 shares, the days-to-cover ratio is presently 1.6 days. Currently, 4.6% of the company's shares are sold short. Get LifeMD News Delivered to You Automatically Sign up to receive the latest news and ratings for LFMD and its competitors with MarketBeat's FREE daily newsletter. Email Address Healthcare Takes A Big Step Forward With The Help Of AI (Ad)The average doctor can diagnose an illness correctly 50-90% of the time. But one innovative company's medical AI gets it right 92%+. Click here to see why this small company is trusted by the Mayo Clinic LFMD Media Mentions By Week LFMD Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. LFMD News Sentiment▼0.120.57▲Average Medical News Sentiment LFMD News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. LFMD Articles This Week▼182▲LFMD Articles Average Week Get LifeMD News Delivered to You Automatically Sign up to receive the latest news and ratings for LFMD and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Auna News Today GeneDx News Today Jin Medical International News Today Pacific Biosciences of California News Today Alector News Today Shattuck Labs News Today Adlai Nortye News Today Oculis News Today ProKidney News Today Travere Therapeutics News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:LFMD) was last updated on 5/14/2024 by MarketBeat.com Staff From Our PartnersHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportRevolutionizing the Green Energy Space and Building Shareholder Value Along the WaySmall Cap SniperInvest Now: Starpax's Cancer Breakthrough Achieving What Others Haven't for a CenturyStarpaxDemocrats Push to Replace Dollar With Digital Coin, Control Currency.Monetary GoldThis 1 Biotech Stock has been shocking the marketsHuge AlertsClaim Your Complimentary Bitcoin RewardCrypto Swap ProfitsREAD THIS – If You Missed Out On The AI BoomBanyan Hill PublishingElon’s New Device is About to Shock the WorldInvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding LifeMD, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
